Clostridioides difficile Infection (CDI)Clostridioides difficile Infection (CDI)
Prevalencia: 500,000 infections/year in the US; 29,000 deaths
Evidence-Ranked Ingredients
| Ingrediente | Calificación | Estudios | Dirección | |
|---|---|---|---|---|
| Saccharomyces boulardii | B | 6 | Positive | Ver → |
About
A toxin-mediated colonic infection caused by C. difficile, typically following antibiotic-induced gut dysbiosis. Toxins A and B cause mucosal inflammation, fluid secretion, and pseudomembrane formation. Recurrence rate is 20-30% after first episode, rising to 40-65% after multiple episodes.
Common Symptoms
Risk Factors
- Recent antibiotic use
- Hospitalization
- Age >65
- PPI use
- Immunosuppression
- Prior CDI episode
- IBD
Frequently Asked Questions
What supplements may help with Clostridioides difficile Infection (CDI)?
How is the evidence for Clostridioides difficile Infection (CDI) supplements graded?
How many studies on Clostridioides difficile Infection (CDI) supplements have been reviewed?
What are common symptoms of Clostridioides difficile Infection (CDI)?
Related Conditions
Afecciones que comparten ingredientes estudiados
Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.